INVESTOR PRESENTATIONS
2022-03-29LL

Immunology Investor Event

Sanofi was pleased to host investors and analysts for its Immunology Investor Event held in person in our new Sanofi Cambridge Headquarters in Cambridge, Massachusetts.

Featuring

  • Paul Hudson
    CEO
  • Bill Sibold
    EVP Sanofi Specialty Care
  • Brian Foard
    Global Head of
    Dupixent Franchise
  • Naimish Patel
    Therapeutic Area Head,
    Immunology &
    Inflammation
  • Frank Nestle
    Global Head of
    Research,
    Chief Scientific Officer
  • John Reed
    Global Head of
    Research and
    Development